Chip Allee, to present at GTCbio's 3rd Assay Development & Screening Technologies Conference
Dr. Allee will speak on the issue of special data management considerations for kinetics assays.


/Biotechnology News Articles/ - MONROVIA, CA, April 23, 2008 - Dr. Chip Allee, CEO at CeuticalSoft Inc. will be giving a presentation at GTCbio's 3rd Assay Development & Screening Technologies Conference on June 5-6, 2008 in San Francisco, CA. Dr. Allee will speak on the issue of special data management considerations for kinetics assays.
Regardless of throughput classification, kinetics assays generate large volumes of data that place extraordinary demands on conventional data handling techniques. This impacts databases, analysis techniques, process automation, data transfer burdens and reporting requirements. Methods for adjusting to high data volume assays (HDV) that include shoehorning existing data systems, adding parallel systems and full replacement will be reviewed. Some discussion will touch on the applicability to high content assay data.
GTCbio's 3rd Assay Development and Screening Technologies conference will provide attendees with critical information to utilize in the discovery and development of assays, while keeping them informed about the latest screening technologies for both high-throughput screening and high-content screening. Topics being covered include cell based assays, high throughput screening, high content screening, in vitro assays and screening, novel assay and screening technologies, and target validation.

Further Related Resources:


Press Release Contact Information:

Rania Hafez
GTCbio
Marketing Director
434 W. Foothill Blvd.
Monrovia, CA
USA 91106
Voice: 626-256-6405
Fax: 626-256-6460
Website: Visit Our Website